Adenovirus-5 E1A: Paradox and paradigm

Nature Reviews Molecular Cell Biology

Volumn 3, Issue 6, 2002, Pages 441-452

  Frisch, Steven M ^a   Mymryk, Joe S ^b  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; VIRUS PROTEIN;

ADENOVIRUS 5; CANCER INHIBITION; CELL ACTIVITY; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR CELL; VIRUS STRAIN;

ADENOVIRUS E1A PROTEINS; ADENOVIRUSES, HUMAN; AMINO ACID SEQUENCE; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENES; RETINOBLASTOMA PROTEIN;

ADENOVIRIDAE; HUMAN ADENOVIRUS TYPE 5; RODENTIA;

EID: 0036088252     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrm827     Document Type: Review

References (146)

1. Adenovirus E1A protein paradigm viral transactivator
2. Partial transformation of primary rat cells by the left most 4.5% fragment of adenovirus 5 DNA
3. Size and location of the transforming region in human adenovirus DNA
4. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
5. Adenovirus E1A proteins and transformation
6. Adenovirus E1A: Remodelling the host cell, a life or death experience
7. Characterization of a human cell line transformed by DNA from human adenovirus type 5
8. Differential transformation of primary human embryo retinal cells by adenovirus E1 regions and combinations of E1A + ras
9. Transformation of human embryonic retinoblasts with SV 40, adenovirus and ras oncogenes
10. Antioncogenic effect of adenovirus E1A in human tumor cells
11. Adenovirus type 5 E1A gene products act as transformation suppressors of the neu oncogene
12. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins
13. Induction of apoptosis by adenovirus type 5 E1A in rat cells requires a proliferation block
14. Induction of apoptosis in fibroblasts by c-myc protein
15. Adenovirus E1A-mediated tumor suppression by a c-erbB-2/neu-independent mechanism
16. Tumour suppressive properties of the adenovirus 5 E1A oncogene
17. Adenovirus 5 E1A-mediated tumor suppression associated with E1A-mediated apoptosis in vivo
18. Transformation-defective adenovirus 5 E1A mutants exhibit antioncogenic properties in human BLM melanoma cells
19. Development of clinical trial of E1A gene therapy targeting HER-2/neuoverexpressing breast and ovarian cancer
20. Adherens junction proteins in tumor progression
21. The role of the cell-adhesion molecule E-cadherin as a tumor-suppressor gene
22. E-cadherin downregulation in cancer: Fuel on the fire?
23. Carcinogenesis: A balance between β-catenin and APC
24. Cadherin and catenin biology represent a global mechanism for epithelial cancer progression
25. E1A induces the expression of epithelial characteristics
26. Evidence for a function of CtBP in epithelial gene regulation and anoikis
27. Intracellular localization of adenovirus type 5 tumor antigens in productively infected cells
28. Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4
29. Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRB and disrupt pRB-E 2F complexes
30. Importance of the ser-132 phosphorylation site in cell transformation and apoptosis induced by the adenovirus type 5 E1A protein
31. Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBR
32. Analysis of DNA binding by the adenovirus 5 E1A oncoprotein
33. Functional interaction of adenovirus E1A with holo-TFIID
34. TATA-binding protein and the retinoblastoma gene product bind to overlapping epitopes on c-Myc and adenovirus E1A protein
35. The zinc finger region of the adenovirus E1A transactivating domain complexes with the TATA box binding protein
36. Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain
37. Subregions of the adenovirus E1A transactivation domain target multiple components of the TFIID complex
38. The viral oncoproteins Ad5 E1A, HPV16 E7 and SV40 TAg bind a common region of the TBP-associated factor-110
39. Transcriptional activation by the adenovirus larger E1A product is mediated by members of the cellular transcription factor ATF family which can directly associate with E1A
40. Promoter targeting by adenovirus E1A through interaction with different cellular DNA-binding domains
41. Interactions between adenovirus E1A and members of the AP-1 family of cellular transcription factors
42. The adenovirus E1A protein is a potent coactivator for thyroid hormone receptors
43. Adenovirus E1A functions as a cofactor for retinoic acid receptor β (rar-β) through direct interaction with rar-β
44. Regulation of the 26S proteasome by adenovirus E1A
45. RACK1 interacts with E1A and rescues E1A-induced yeast growth inhibition and mammalian cell apoptosis
46. CBP/p300 in cell growth, transformation, and development
47. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300
48. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
49. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
50. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
51. A novel Rb- and p300-binding protein inhibits transactivation by MyoD
52. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
53. The PCAF acetylase complex as a potential tumor suppressor
54. E1A directly binds and regulates the PCAF acetyltransferase
55. P53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage
56. DNA damage activates p53 through a phosphorylation-acetylation cascade
57. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation
58. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program
59. Identification of human proteins functionally conserved with the yeast putative adaptors ADA2 and GCN5
60. Retinoblastoma growth suppressor and a 300-kDa protein appear to regulate cellular DNA synthesis
61. Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth
62. E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products
63. Interactions between cell growth regulating domains in the products of the adenovirus E1A oncogene
64. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region
65. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases
66. The viral oncoprotein E1A blocks transforming growth factor β-mediated induction of p21/WAF1/Cip1 and p 15/INK 4B
67. TGF-β-stimulated cooperation of smad proteins with the coactivators CBP/p300
68. Antisense-mediated depletion of p300 in human cells leads to premature G1 exit and up-regulation of c-MYC
69. Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling
70. CBP/p300 histone acetyl-transferase activity is important for the G1/S transition
71. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
72. The adenovirus E1A-associated kinase consists of cyclin E-p33 and cyclin A-p33
73. Phosphorylation of the adenovirus E1A-associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells
74. The adenovirus E1A 289R and 243R proteins inhibit the phosphorylation of p300
75. Mutations truncating the EP300 acetylase in human cancers
76. Suppression of tumor growth through disruption of hypoxia-inducible transcription
77. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells
78. 2-terminal and conserved region 2 domains of adenovirus E1A mediate two distinct mechanisms of tumor suppression
79. The epithelial cell default-phenotype hypothesis and its implications for cancer
80. The CtBP family: Enigmatic and enzymatic transcriptional co-repressors
81. CtBP, an unconventional transcriptional corepressor in development and oncogenesis
82. Molecular cloning and characterization of a cellular phosphoprotein that interacts with a conserved carboxy-terminal domain of adenovirus E1A involved in negative modulation of oncogenic transformation
83. A mechanism for Rb/p130-mediated transcription repression involving recruitment of the CtBP corepressor
84. Functional link of BRCA1 and AT gene product in DNA damage response
85. Regulation of corepressor function by nuclear NADH
86. Anoikis mechanisms
87. Disruption of epithelial cell-matrix interactions induces apoptosis
88. Indication of hypoxic areas in tumours from in vivo NADH fluorescence
89. Bcl-2 prevents mitochonddal permeability transition and cytochrome c release via maintenance of reduced pyridine nucleotides
90. Effects of Ad5 E1A mutant viruses on the cell cycle in relation to the binding of cellular proteins including the retinoblastoma protein and cyclin A
91. Functional interactions within adenovirus E1A protein complexes
92. The p400 complex is an essential E1A transformation target
93. Recruitment of TRRAP required for oncogenic transformation by E1A
94. The Swi/Snf family nucleosome-remodeling complexes and transcriptional control
95. Involvement of the TIP 60 histone acetylase complex in DNA repair and apoptosis
96. The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins
97. Function of the c-Myc oncoprotein in chromatin remodeling and transcription
98. The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
99. Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression
100. Association between an oncogene and an anti-oncogene: The adenovirus E1A proteins bind to the retinoblastoma gene product
101. Binding of the Rb 1 protein to E1A products is required for adenovirus transformation
102. Sibling rivalry in the E2F family
103. Cancer cell cycles
104. P107 and p130: Versatile proteins with interesting pockets
105. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation
106. Independent regions of adenovirus E1A are required for binding to and dissociation of E2F-protein complexes
107. Identification of distinct roles for separate E1A domains in disruption of E2F complexes
108. ARF tumor suppressor
109. The retinoblastoma gene: A prototypic, and multifunctional tumor suppressor
110. Rb targets histone H3 methylation and HP1 to promoters
111. Cyclin A is a functional target of retinoblastoma tumor suppressor protein mediated cell cycle arrest
112. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins
113. Role of the LXCXE binding site in Rb function
114. Establishment of irreversible growth arrest in myogenic differentiation requires the RB LXCXE-binding function
115. Acetylation control of the retinoblastoma tumour-suppressor protein
116. RB regulates the stability and the apeptotic function of p53 via MDM2
117. Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis
118. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins
119. Loss of Ras activity in Saccharomyces cerevisiae is suppressed by disruptions of a new kinase gene, YAKI, whose product may act downstream of the cAMP-dependent protein kinase
120. Suppression of a yeast cyclic AMP-dependent protein kinase defect by overexpression of SOK1, a yeast gene exhibiting sequence similarity to a developmentally regulated mouse gene
121. Minibrain: A new protein kinase family involved in postembryonic neurogenesis in Drosophila
122. YakA, a protein kinase required for the transition from growth to development in Dictyostelium
123. Sequence characteristics, subcellular localization, and substrate specificity of DYRK-related kinases, a novel family of dual specificity protein kinases
124. Protein kinase Dyrk1 activates cAMP response element-binding protein during neuronal differentiation in hippocampal progenitor cells
125. Dyrk, a dual specificity protein kinase with unique structural features whose activity is dependent on tyrosine residues between subdomains VII and VIII
126. Localisation of a human homologue of the Drosophila mnb and rat Dyrk genes to chromosome 21q22
127. Interaction of the E1A oncoprotein with Yaktp, a novel regulator of yeast pseudohyphal differentiation, and related mammalian kinases
128. A region in the C-terminus of adenovirus 2/5E1A protein is required for association with a cellular phosphoprotein and important for the negative modulation of T24-ras mediated transformation, tumorigenesis and metastasis
129. Differentially expressed genes identified in human melanoma cell lines with different metastatic behaviour using high density oligonucleotide arrays
130. Identification of genes involved in epithelial-mesenchymal transition and tumor progression
131. Adenovirus E1A proteins inhibit activation of transcription by p53
132. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation
133. Recruitment of p300/CBP in p53-dependent signal pathways
134. Binding and modulation of p53 by p300/CBP coactivators
135. CIP/WAF1
136. E1A can provoke G1 exit that is refractory to p21 and independent of activating Cdk2
137. Deregulation of p53/p21/Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after γ-irradiation
138. Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells
139. P21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells
140. Kp1 by the viral E1A oncoprotein in TGFβ-treated cells
141. Interaction of p27 with E1A and its effect on CDK kinase activity
142. Kip1
143. The oncogenicity, of human adenoviruses in hamsters
144. Transformation of rat cells by DNA of human adenovirus 5
145. Cellular targets for transformation by the adenovirus E1A proteins
146. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor